Sonic Healthcare Limited
Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal te… Read more
Sonic Healthcare Limited (SKHCF) - Net Assets
Latest net assets as of June 2025: $8.47 Billion USD
Based on the latest financial reports, Sonic Healthcare Limited (SKHCF) has net assets worth $8.47 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($16.05 Billion) and total liabilities ($7.58 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $8.47 Billion |
| % of Total Assets | 52.78% |
| Annual Growth Rate | 19.27% |
| 5-Year Change | 30.27% |
| 10-Year Change | 127.0% |
| Growth Volatility | 67.66 |
Sonic Healthcare Limited - Net Assets Trend (1989–2025)
This chart illustrates how Sonic Healthcare Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sonic Healthcare Limited (1989–2025)
The table below shows the annual net assets of Sonic Healthcare Limited from 1989 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $8.47 Billion | +4.93% |
| 2024-06-30 | $8.08 Billion | +1.93% |
| 2023-06-30 | $7.92 Billion | +6.65% |
| 2022-06-30 | $7.43 Billion | +14.20% |
| 2021-06-30 | $6.50 Billion | +14.83% |
| 2020-06-30 | $5.66 Billion | +3.14% |
| 2019-06-30 | $5.49 Billion | +28.23% |
| 2018-06-30 | $4.28 Billion | +9.09% |
| 2017-06-30 | $3.93 Billion | +5.18% |
| 2016-06-30 | $3.73 Billion | +12.23% |
| 2015-06-30 | $3.33 Billion | +6.98% |
| 2014-06-30 | $3.11 Billion | +6.54% |
| 2013-06-30 | $2.92 Billion | +11.80% |
| 2012-06-30 | $2.61 Billion | +3.73% |
| 2011-06-30 | $2.52 Billion | -1.65% |
| 2010-06-30 | $2.56 Billion | +1.05% |
| 2009-06-30 | $2.53 Billion | +29.05% |
| 2008-06-30 | $1.96 Billion | +36.40% |
| 2007-06-30 | $1.44 Billion | +10.45% |
| 2006-06-30 | $1.30 Billion | +47.55% |
| 2005-06-30 | $882.63 Million | +4.11% |
| 2004-06-30 | $847.79 Million | +1.98% |
| 2003-06-30 | $831.29 Million | -0.74% |
| 2002-06-30 | $837.47 Million | +37.65% |
| 2001-06-30 | $608.42 Million | +126.40% |
| 2000-06-30 | $268.74 Million | +379.05% |
| 1999-06-30 | $56.10 Million | +1.35% |
| 1998-06-30 | $55.35 Million | +3.13% |
| 1997-06-30 | $53.67 Million | +45.73% |
| 1996-06-30 | $36.83 Million | +87.25% |
| 1995-06-30 | $19.67 Million | +21.25% |
| 1994-06-30 | $16.22 Million | +108.01% |
| 1993-06-30 | $7.80 Million | +44.06% |
| 1992-06-30 | $5.41 Million | +7.27% |
| 1991-06-30 | $5.05 Million | -62.66% |
| 1990-06-30 | $13.51 Million | -9.16% |
| 1989-06-30 | $14.88 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sonic Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 354867600000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $3.54 Billion | 42.58% |
| Common Stock | $4.15 Billion | 49.84% |
| Other Comprehensive Income | $637.37 Million | 7.66% |
| Total Equity | $8.32 Billion | 100.00% |
Sonic Healthcare Limited Competitors by Market Cap
The table below lists competitors of Sonic Healthcare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SCB X Public Company Limited
BK:SCB
|
$6.95 Billion |
|
Powerchip Semiconductor Manufacturing Corp.
TW:6770
|
$6.96 Billion |
|
Nedbank Group Limited
PINK:NDBKF
|
$6.96 Billion |
|
Axsome Therapeutics Inc
NASDAQ:AXSM
|
$6.97 Billion |
|
The Federal Bank Limited
NSE:FEDERALBNK
|
$6.95 Billion |
|
KINSALE CAP.GRP.INC. -01
F:KCH
|
$6.94 Billion |
|
Hanwha Systems Co Ltd
KO:272210
|
$6.94 Billion |
|
Stockland Corp Ltd
STU:LN1
|
$6.94 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sonic Healthcare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,917,623,000 to 8,323,498,000, a change of 405,875,000 (5.1%).
- Net income of 513,597,000 contributed positively to equity growth.
- Dividend payments of 514,033,000 reduced retained earnings.
- Other comprehensive income increased equity by 412,937,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $513.60 Million | +6.17% |
| Dividends Paid | $514.03 Million | -6.18% |
| Other Comprehensive Income | $412.94 Million | +4.96% |
| Other Changes | $-6.62 Million | -0.08% |
| Total Change | $- | 5.13% |
Book Value vs Market Value Analysis
This analysis compares Sonic Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.90x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 55.93x to 0.90x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1989-06-30 | $0.28 | $15.60 | x |
| 1990-06-30 | $0.25 | $15.60 | x |
| 1991-06-30 | $0.09 | $15.60 | x |
| 1992-06-30 | $0.10 | $15.60 | x |
| 1993-06-30 | $0.13 | $15.60 | x |
| 1994-06-30 | $0.25 | $15.60 | x |
| 1995-06-30 | $0.26 | $15.60 | x |
| 1996-06-30 | $0.43 | $15.60 | x |
| 1997-06-30 | $0.45 | $15.60 | x |
| 1998-06-30 | $0.45 | $15.60 | x |
| 1999-06-30 | $0.44 | $15.60 | x |
| 2000-06-30 | $1.82 | $15.60 | x |
| 2001-06-30 | $2.96 | $15.60 | x |
| 2002-06-30 | $3.39 | $15.60 | x |
| 2003-06-30 | $3.20 | $15.60 | x |
| 2004-06-30 | $3.23 | $15.60 | x |
| 2005-06-30 | $3.25 | $15.60 | x |
| 2006-06-30 | $4.45 | $15.60 | x |
| 2007-06-30 | $4.69 | $15.60 | x |
| 2008-06-30 | $5.85 | $15.60 | x |
| 2009-06-30 | $6.84 | $15.60 | x |
| 2010-06-30 | $6.54 | $15.60 | x |
| 2011-06-30 | $6.45 | $15.60 | x |
| 2012-06-30 | $6.61 | $15.60 | x |
| 2013-06-30 | $7.28 | $15.60 | x |
| 2014-06-30 | $7.65 | $15.60 | x |
| 2015-06-30 | $8.09 | $15.60 | x |
| 2016-06-30 | $8.87 | $15.60 | x |
| 2017-06-30 | $9.14 | $15.60 | x |
| 2018-06-30 | $9.85 | $15.60 | x |
| 2019-06-30 | $12.02 | $15.60 | x |
| 2020-06-30 | $11.68 | $15.60 | x |
| 2021-06-30 | $13.26 | $15.60 | x |
| 2022-06-30 | $15.06 | $15.60 | x |
| 2023-06-30 | $16.38 | $15.60 | x |
| 2024-06-30 | $16.60 | $15.60 | x |
| 2025-06-30 | $17.29 | $15.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sonic Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.17%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.32%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.93x
- Recent ROE (6.17%) is above the historical average (5.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1989 | -0.09% | -0.06% | 0.86x | 1.71x | $-1.50 Million |
| 1990 | -10.09% | -5.20% | 1.09x | 1.77x | $-2.71 Million |
| 1991 | -169.76% | -27.83% | 1.71x | 3.56x | $-9.07 Million |
| 1992 | 0.76% | 0.12% | 1.97x | 3.10x | $-500.30K |
| 1993 | 15.49% | 3.73% | 1.89x | 2.20x | $428.20K |
| 1994 | 23.02% | 11.20% | 0.97x | 2.11x | $2.11 Million |
| 1995 | 21.89% | 7.56% | 1.32x | 2.19x | $2.34 Million |
| 1996 | 18.49% | 7.73% | 0.83x | 2.89x | $3.13 Million |
| 1997 | 14.81% | 5.95% | 1.16x | 2.14x | $2.58 Million |
| 1998 | 20.74% | 0.00% | 0.00x | 2.19x | $5.94 Million |
| 1999 | 31.11% | 0.00% | 0.00x | 2.78x | $11.84 Million |
| 2000 | -1.18% | 0.00% | 0.00x | 2.70x | $-30.10 Million |
| 2001 | 0.01% | 0.01% | 0.49x | 2.12x | $-60.04 Million |
| 2002 | 0.19% | 0.18% | 0.53x | 1.92x | $-81.69 Million |
| 2003 | 0.11% | 0.09% | 0.62x | 1.86x | $-82.20 Million |
| 2004 | -0.03% | -0.02% | 0.61x | 1.97x | $-86.26 Million |
| 2005 | -1.35% | -0.88% | 0.78x | 1.96x | $-100.39 Million |
| 2006 | 13.39% | 10.46% | 0.70x | 1.83x | $43.56 Million |
| 2007 | 13.95% | 10.55% | 0.65x | 2.04x | $56.12 Million |
| 2008 | 12.57% | 10.51% | 0.64x | 1.86x | $50.12 Million |
| 2009 | 6.77% | 5.72% | 0.63x | 1.88x | $-81.66 Million |
| 2010 | 11.47% | 9.86% | 0.61x | 1.90x | $37.60 Million |
| 2011 | 11.71% | 9.55% | 0.65x | 1.87x | $43.10 Million |
| 2012 | 12.20% | 9.51% | 0.67x | 1.90x | $57.05 Million |
| 2013 | 11.57% | 9.78% | 0.62x | 1.91x | $45.51 Million |
| 2014 | 12.49% | 9.99% | 0.66x | 1.88x | $76.72 Million |
| 2015 | 10.62% | 8.40% | 0.65x | 1.94x | $20.29 Million |
| 2016 | 12.32% | 9.12% | 0.67x | 2.01x | $85.09 Million |
| 2017 | 11.17% | 8.46% | 0.64x | 2.06x | $44.83 Million |
| 2018 | 11.39% | 8.69% | 0.67x | 1.96x | $57.87 Million |
| 2019 | 10.16% | 9.05% | 0.61x | 1.84x | $8.49 Million |
| 2020 | 9.47% | 7.72% | 0.56x | 2.18x | $-29.63 Million |
| 2021 | 20.60% | 15.02% | 0.74x | 1.84x | $676.54 Million |
| 2022 | 20.08% | 15.64% | 0.74x | 1.73x | $733.25 Million |
| 2023 | 8.85% | 8.41% | 0.60x | 1.75x | $-88.67 Million |
| 2024 | 6.46% | 5.72% | 0.60x | 1.87x | $-280.67 Million |
| 2025 | 6.17% | 5.32% | 0.60x | 1.93x | $-318.75 Million |
Industry Comparison
This section compares Sonic Healthcare Limited's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sonic Healthcare Limited (SKHCF) | $8.47 Billion | -0.09% | 0.89x | $6.95 Billion |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |